Oblenio Bio
Immunology & Inflammation Therapeutics

Oblenio Bio: Ownership & structure

Data updated Nov 20, 2026 · Back to the company report

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
Aditum BioVia a fund
5 portfolio companies: Eli Lilly and Company, Kalexo Bio, Via Nova 2.0 and 2 more
GVVia a fund
569 portfolio companies